GENERIX GROUP (GENX.PA) Fundamental Analysis & Valuation

EPA:GENX • FR0010501692

Current stock price

9.7 EUR
+0.04 (+0.41%)
Last:

This GENX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. GENX.PA Profitability Analysis

1.1 Basic Checks

  • GENX had positive earnings in the past year.
GENX.PA Yearly Net Income VS EBIT VS OCF VS FCFGENX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 5M 10M

1.2 Ratios

Industry RankSector Rank
ROA 2.84%
ROE 7.39%
ROIC 7.99%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GENX.PA Yearly ROA, ROE, ROICGENX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 2 4 6 8 10

1.3 Margins

Industry RankSector Rank
OM 7.39%
PM (TTM) 4.04%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GENX.PA Yearly Profit, Operating, Gross MarginsGENX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 20 40 60 80

2

2. GENX.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), GENX is creating some value.
  • Compared to 1 year ago, GENX has more shares outstanding
  • GENX has a better debt/assets ratio than last year.
GENX.PA Yearly Shares OutstandingGENX.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
GENX.PA Yearly Total Debt VS Total AssetsGENX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 2.75 indicates that GENX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • A Debt/Equity ratio of 0.25 indicates that GENX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 2.75
ROIC/WACC1.18
WACC6.77%
GENX.PA Yearly LT Debt VS Equity VS FCFGENX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M 20M 30M 40M

2.3 Liquidity

  • GENX has a Current Ratio of 0.98. This is a bad value and indicates that GENX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • GENX has a Quick Ratio of 0.98. This is a bad value and indicates that GENX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
GENX.PA Yearly Current Assets VS Current LiabilitesGENX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M

3

3. GENX.PA Growth Analysis

3.1 Past

  • The earnings per share for GENX have decreased strongly by -33.12% in the last year.
  • The Earnings Per Share has been growing by 42.98% on average over the past years. This is a very strong growth
  • The Revenue has been growing slightly by 5.29% in the past year.
  • Measured over the past years, GENX shows a small growth in Revenue. The Revenue has been growing by 6.05% on average per year.
EPS 1Y (TTM)-33.12%
EPS 3Y11.67%
EPS 5Y42.98%
EPS Q2Q%-78.02%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y3.31%
Revenue growth 5Y6.05%
Sales Q2Q%2.07%

3.2 Future

  • GENX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.42% yearly.
  • GENX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.01% yearly.
EPS Next Y-28.57%
EPS Next 2Y-4.88%
EPS Next 3Y-4.22%
EPS Next 5Y-3.42%
Revenue Next Year4.41%
Revenue Next 2Y5.53%
Revenue Next 3Y4.84%
Revenue Next 5Y5.01%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GENX.PA Yearly Revenue VS EstimatesGENX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
GENX.PA Yearly EPS VS EstimatesGENX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15 0.2

0

4. GENX.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 80.83, the valuation of GENX can be described as expensive.
  • Compared to an average S&P500 Price/Earnings ratio of 27.42, GENX is valued quite expensively.
  • GENX is valuated quite expensively with a Price/Forward Earnings ratio of 63.40.
  • When comparing the Price/Forward Earnings ratio of GENX to the average of the S&P500 Index (22.24), we can say GENX is valued expensively.
Industry RankSector Rank
PE 80.83
Fwd PE 63.4
GENX.PA Price Earnings VS Forward Price EarningsGENX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.42
GENX.PA Per share dataGENX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • GENX's earnings are expected to decrease with -4.22% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.88
EPS Next 2Y-4.88%
EPS Next 3Y-4.22%

0

5. GENX.PA Dividend Analysis

5.1 Amount

  • GENX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GENX.PA Fundamentals: All Metrics, Ratios and Statistics

GENERIX GROUP

EPA:GENX (8/23/2022, 7:00:00 PM)

9.7

+0.04 (+0.41%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap220.19M
Revenue(TTM)84.50M
Net Income(TTM)3.41M
Analysts85.71
Price Target9.69 (-0.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 80.83
Fwd PE 63.4
P/S 2.61
P/FCF N/A
P/OCF N/A
P/B 4.77
P/tB N/A
EV/EBITDA 20.42
EPS(TTM)0.12
EY1.24%
EPS(NY)0.15
Fwd EY1.58%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.72
BVpS2.03
TBVpSN/A
PEG (NY)N/A
PEG (5Y)1.88
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 2.84%
ROE 7.39%
ROCE N/A
ROIC 7.99%
ROICexc N/A
ROICexgc 40.65%
OM 7.39%
PM (TTM) 4.04%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 2.75
F-Score7
WACC6.77%
ROIC/WACC1.18
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.12%
EPS 3Y11.67%
EPS 5Y42.98%
EPS Q2Q%-78.02%
EPS Next Y-28.57%
EPS Next 2Y-4.88%
EPS Next 3Y-4.22%
EPS Next 5Y-3.42%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y3.31%
Revenue growth 5Y6.05%
Sales Q2Q%2.07%
Revenue Next Year4.41%
Revenue Next 2Y5.53%
Revenue Next 3Y4.84%
Revenue Next 5Y5.01%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

GENERIX GROUP / GENX.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GENERIX GROUP?

ChartMill assigns a fundamental rating of 3 / 10 to GENX.PA.


What is the valuation status of GENERIX GROUP (GENX.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to GENERIX GROUP (GENX.PA). This can be considered as Overvalued.


How profitable is GENERIX GROUP (GENX.PA) stock?

GENERIX GROUP (GENX.PA) has a profitability rating of 4 / 10.


How financially healthy is GENERIX GROUP?

The financial health rating of GENERIX GROUP (GENX.PA) is 4 / 10.